ACST
Closed
Acasti Pharma Inc
3.28
-0.09 (-2.67%)
Last Update: 22 Nov 2024 17:30:00
Yesterday: 3.37
Day's Range: 3.07 - 3.4
Send
sign up or login to leave a comment!
When Written:
0.46
Acasti Pharma Inc is a biopharmaceutical company that develops and commercializes prescription drugs for the treatment of cardiovascular diseases. The company's lead product candidate is CaPre, a purified omega-3 phospholipid concentrate derived from krill oil that is being developed for the treatment of severe hypertriglyceridemia. Acasti Pharma is headquartered in Laval, Quebec, Canada and was founded in 2008. The company is publicly traded on the NASDAQ and Toronto Stock Exchange under the ticker symbol ACST.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








